about
Sequential processing of the Toxoplasma apicoplast membrane protein FtsH1 in topologically distinct domains during intracellular traffickingDiscovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs.Socio-demographic determinants of Toxoplasma gondii seroprevalence in migrant workers of Peninsular Malaysia.Toxoplasma gondii down modulates cadherin expression in skeletal muscle cells inhibiting myogenesis.IgG avidity antibodies against Toxoplasma gondii in high risk females of reproductive age group in India.Seroepidemiology of Toxoplasma gondii Infection among healthy blood donors in Taiwan.Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW CameroonReal-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain.Seroprevalence of Toxoplasma gondii and associated risk factors among HIV-infected women within reproductive age group at Mizan Aman General Hospital, Southwest Ethiopia: a cross sectional study.Protein palmitoylation and pathogenesis in apicomplexan parasites.Toxoplasma gondii - Prevalence and Risk Factors in HIV-infected Patients from Songklanagarind Hospital, Southern Thailand.Efficacy of the Bunium persicum (Boiss) Essential Oil against Acute Toxoplasmosis in Mice Model.Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coliReverse enzyme-linked immunosorbent assay using monoclonal antibodies against SAG1-related sequence, SAG2A, and p97 antigens from Toxoplasma gondii to detect specific immunoglobulin G (IgG), IgM, and IgA antibodies in human sera.Identification and real-time expression analysis of selected Toxoplasma gondii in-vivo induced antigens recognized by IgG and IgM in sera of acute toxoplasmosis patients.Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, QatarPathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern BrazilSeroprevalence and risk factors associated with ovine toxoplasmosis in Northeast BrazilEnvironmental determinants of spatial and temporal variations in the transmission of Toxoplasma gondii in its definitive hosts.Toward automated oligosaccharide synthesis.Zoonoses in South-East Asia: a regional burden, a global threat.Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran.Patient with toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case reportToxoplasmosis in a woodchuck (Marmota monax) and two American red squirrels (Tamiasciurus hudsonicus).Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8.Seroprevalence of Toxoplasma gondii infection among childbearing age women in Kerman city, southeastern Iran.Risk and other factors associated with toxoplasmosis and toxocariasis in pregnant women from southern Brazil.Molecular detection of Toxoplasma gondii in water sources of district Nowshehra, Khyber Pakhtunkhwa, Pakistan.Questionnaire survey on the occurrence of risk factors for Toxoplasma gondii infection amongst farmers in Thika District, Kenya.Prevalence of Toxoplasma gondii Infection among Healthy Blood Donors in Northeast of Iran.The protozoan pathogen Toxoplasma gondii targets the paracellular pathway to invade the intestinal epithelium.Consumption of Domestic Cat in Madagascar: Frequency, Purpose, and Health Implications
P2860
Q30377186-2B915F72-ED53-42CE-8BE4-0D847A14D700Q30576511-C7952F43-C668-4881-85E0-7A9E23C67F40Q33691709-78524EB8-B4A5-4BAC-852B-B9ADB803E1AAQ33904826-DF74774E-C9A3-416A-A6B9-EE313060DCC3Q34411023-067F4F53-FB50-4EBB-8D13-C196409CF36EQ34469348-B3026321-128F-44B6-AA18-A9417CA34B60Q36104599-998D1B4B-E305-4E41-91FB-13923FB6EA6CQ36192240-D9017509-BA2B-4337-960B-9F21FDEBBA83Q36261755-F05FC1F2-2266-4221-B0E5-A37B0E1D7349Q36316026-2BD2C16D-F2F6-4446-AF9F-660FEDA03F51Q36316274-9790FEEA-82EC-4814-A270-A5E3E23AFF1BQ36495995-7599572A-AFE2-4C33-9757-0E6E60051767Q36571364-1EDEB435-F96B-4101-AABA-A37E2ECFDC2FQ36844910-86A04BD0-0657-4B85-AFD9-28F627D0CBA4Q36964387-9F30304D-80AF-40F7-9772-56FE9D112454Q36981941-3ACC6B38-C7C8-4DC2-80DC-E1F9DBB374B5Q37007536-D923B62D-FFE2-4AAE-BAF9-E4694B414FE1Q37032923-C2F05223-28FA-4F99-9F49-FB66EFF1D96FQ37390732-816EFD8A-93E4-4FF0-9612-172C9F7CFEA0Q37962848-33A1C1C4-CB92-454D-9D13-25BDAE4799CEQ38090749-6AC768EB-D49D-401F-8509-5032E6E05357Q39204972-4A384BE8-26D2-42FE-8CE1-6A4FFB400F61Q39311853-B267F3EE-A49F-4C13-8B54-BDB6CAE3DE7BQ39821027-D76F3AA5-3DFF-4BB5-991B-ADBCC1C1A6ADQ40171442-17B1E9D9-2196-44B0-9B52-D00C6A6A53ABQ40439454-0B050272-B3F7-452B-9B6A-F33C2520E246Q40614724-A5844962-2057-4E24-9894-33A0C7CE6471Q43794619-85A2D4EA-ABED-4C5D-8DD1-8562761949ACQ43818841-6F6B6F50-9F1F-44E2-8F50-B7F29AA08E39Q47407143-99DDC920-655D-4B0F-9E3C-5058CE6D1D77Q48461259-9B5B5EF8-34FB-40FF-ADB8-E606B4C9EA9FQ58142085-AF8B26D6-E91B-46A3-95F1-959AAA9AE817
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Toxoplasmosis: beyond animals to humans.
@ast
Toxoplasmosis: beyond animals to humans.
@en
Toxoplasmosis: beyond animals to humans.
@nl
type
label
Toxoplasmosis: beyond animals to humans.
@ast
Toxoplasmosis: beyond animals to humans.
@en
Toxoplasmosis: beyond animals to humans.
@nl
prefLabel
Toxoplasmosis: beyond animals to humans.
@ast
Toxoplasmosis: beyond animals to humans.
@en
Toxoplasmosis: beyond animals to humans.
@nl
P356
P1476
Toxoplasmosis: beyond animals to humans.
@en
P2093
Yaowalark Sukthana
P304
P356
10.1016/J.PT.2006.01.007
P577
2006-01-30T00:00:00Z